医生间手动血栓抽吸使用差异与STEMI直接PCI结局的关联:NCDR CathPCI注册研究
抽吸使用率在2011年达峰13.8%后下降超9%至2016年中期4.7%,工具变量分析显示抽吸与院内死亡无差异,但院内卒中风险小幅增加(调整RD 0.14%)。
要点
- STEMI直接PCI中血栓抽吸使用率自2011年峰值13.8%下降超50%至2016年中期4.7%。
- 工具变量分析显示抽吸与院内死亡无差异(调整RD -0.18%,95%CI -0.53%至0.16%)。
核心结论
- 在大规模全国性分析中,STEMI直接PCI期间血栓抽吸使用自2011年以来下降超过50%,至2016年中期低于5%。
- 选择性使用抽吸与院内卒中风险小幅增加相关,至180天随访其他结局无差异。
研究设计与样本
- 回顾性队列研究,使用美国国家心血管数据注册(NCDR)CathPCI注册2009年7月1日至2016年6月30日数据,评估趋势与院内结局。
- 通过CMS链接患者子分析评估至180天结局,时间段为2009年7月1日至2014年12月31日。
- 采用工具变量分析(工具变量为操作者偏好)校正治疗选择偏倚,数据分析时间为2017年2月1日至2018年4月1日。
主要发现
- 抽吸使用率从2009年至2011年上升,峰值13.8%,随后下降超过9%,至2016年中期达4.7%。
- 总体抽吸使用率为10.8%,操作者组中位数最低0%,最高33.8%。
临床怎么用
- 当前STEMI直接PCI中常规手动血栓抽吸使用已显著下降,临床决策应基于个体化评估。
- 选择性使用抽吸时需权衡院内卒中风险的小幅增加与缺乏明确获益的证据。
局限性
- 回顾性观察性设计,尽管采用工具变量分析,仍可能存在未测量混杂。
- 180天结局分析仅限CMS链接患者子集,可能影响普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Following negative randomized clinical trials, US guidelines downgraded support for routine manual aspiration thrombectomy (AT) during primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI). However, some PCI operators continue to endorse a clinical benefit with AT use despite the lack of supportive data. OBJECTIVE: To examine temporal trends and comparative outcomes of AT use during pPCI for STEMI. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of the National Cardiovascular Data Registry (NCDR) CathPCI Registry from July 1, 2009, to June 30, 2016, to assess temporal trends and in-hospital outcomes associated with AT use. To evaluate outcomes through 180 days, a subanalysis was conducted among Centers for Medicare and Medicaid Services-linked patients from July 1, 2009, through December 31, 2014. The comparative effectiveness analysis was performed using instrumental variable analyses to account for treatment selection bias. The instrumental variable was operator's preference to use AT during pPCI. Data were analyzed between February 1, 2017, and April 1, 2018. EXPOSURES: Aspiration thrombectomy use during pPCI for STEMI. MAIN OUTCOMES AND MEASURES: Primary outcomes included in-hospital stroke and death. Secondary outcomes included heart failure, stroke, all-cause rehospitalization, and death through 180 days of follow-up. RESULTS: Among all pPCIs performed (683 584), the mean (SD) age of patients was 61.7 (12.8) years, 489 257 were male (71.6%), and 596 384 were white (87.2%). Among patients undergoing pPCI, AT use increased from 2009 through 2011, with peak use of 13.8%. This was followed by a decline of more than 9%, reaching 4.7% by mid-2016. Overall, AT was used in 10.8% of pPCIs (lowest operator group median, 0%; highest operator group median, 33.8%). After instrumental variable analysis, AT use was associated with no difference in in-hospital death (adjusted absolute risk difference, -0.18%; 95% CI, -0.53% to 0.16%; P = .29) and a small increase in in-hospital stroke (adjusted RD, 0.14%; 95% CI, 0.01%-0.30%; P = .03). Among Centers for Medicare and Medicaid Services-linked patients, AT use was not associated with differences in death, heart failure, stroke, or rehospitalization at 180 days. CONCLUSIONS AND RELEVANCE: In this large, nationwide analysis, AT use during STEMI pPCI declined by more than 50% since 2011, with use as of mid-2016 at less than 5%. Selective AT use was associated with a small excess risk of in-hospital stroke and no difference in other outcomes through 180 days of follow-up.
引用
- Secemsky EA, Ferro EG, Rao SV, et al. Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry. JAMA Cardiol. 2019. PMID: 30624549. doi:10.1001/jamacardio.2018.4472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。